YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

MDXXF
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

finance.yahoo.comPOSITIVO

Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New Zealand

Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New Zealand·globenewswire.com TAIRĀWHITI, New Zealand and TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Rua Bioscience Limited (NZX: RUA) ("Rua") and PharmAla Biotech Hol…

0512.HKMDMA.CNMDMAMDXXFRUA
Fuente original ↗Analizar →
finance.yahoo.comPOSITIVO

PharmAla Biotech Signs Term Sheet for $100 Million U.S. Licensing Deal for ALA-002 MDMA Therapy (MDXXF)

medical research 12 ©sharevault.com The proposed agreement would grant Jupiter Neurosciences exclusive U.S. rights to PharmAla’s lead psychedelic drug candidate while allowing PharmAla to retain international commercialization rights. Key…

JUNSMDXXF
Fuente original ↗Analizar →
globenewswire.comPOSITIVO

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel deri…

MDMAMDXXF
Fuente original ↗Analizar →
globenewswire.comPOSITIVO

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel deri…

MDMAMDXXFSAP
Fuente original ↗Analizar →